Goldman Sachs
SMTI icon

Goldman Sachs’s Sanara MedTech SMTI Stock Holding History

Goldman Sachs’s Portfolio SMTI Stock Details SMTI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.75M Buy
74,198
+52,613
+244% +$1.09M ﹤0.01% 4785
2026
Q1 		$371K Buy
+21,585
New +$444K ﹤0.01% 5776
2025
Q4 		– Sell
-9,623
Closed -$305K – 6787
2025
Q3 		$305K Buy
+9,623
New +$290K ﹤0.01% 5741
2025
Q2 		– Sell
-6,581
Closed -$203K – 6393
2025
Q1 		$203K Sell
6,581
-5,751
-47% -$195K ﹤0.01% 5636
2024
Q4 		$409K Buy
+12,332
New +$418K ﹤0.01% 5348
2023
Q2 		– Sell
-9,214
Closed -$380K – 6044
2023
Q1 		$380K Buy
+9,214
New +$388K ﹤0.01% 4985

Other funds holding SMTI

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return
SWM
Stonebridge Wealth Management Oak Brook, Illinois $112M AUM 23.07% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Squarepoint
Squarepoint New York $90.5B AUM 33.95% 1-Year Est. Return
Jane Street
Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return

Goldman Sachs's SMTI Position: Q2 2026 in Review

Goldman Sachs increased its Sanara MedTech (SMTI) stake by 244% in Q2 2026, buying an estimated $1.09M and bringing the position to 74,198 shares worth $1.75M. The position accounts for ﹤0.01% of the portfolio, ranked #4785.

Goldman Sachs first reported a position in SMTI in Q1 2023 and has held it in 6 quarters since. 75 funds tracked by Wall St. Rank hold SMTI as of Q2 2026.

  • Goldman Sachs held 74,198 shares of Sanara MedTech worth $1.75M as of Q2 2026.
  • Goldman Sachs bought 52,613 Sanara MedTech shares in Q2 2026, an estimated $1.09M.
  • Sanara MedTech made up ﹤0.01% of Goldman Sachs's portfolio in Q2 2026, its #4785 holding.
  • Goldman Sachs first reported a position in Sanara MedTech in Q1 2023 and has held it in 6 quarters since.
  • 75 funds tracked by Wall St. Rank held Sanara MedTech as of Q2 2026.

Based on Goldman Sachs's 13F filing for Q2 2026, filed 14 Aug 2026.